tiprankstipranks
Trending News
More News >
DarioHealth Corp (DRIO)
NASDAQ:DRIO
US Market

DarioHealth (DRIO) Earnings Dates, Call Summary & Reports

Compare
269 Followers

Earnings Data

Report Date
Aug 18, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.2
Last Year’s EPS
-0.08
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 14, 2025
|
% Change Since: 0.00%
|
Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Neutral
DarioHealth reported strong client acquisition and improvements in gross margins and operating expenses. However, the quarter faced challenges with sequential revenue decline and large client contract transitions. Despite these challenges, the company remains optimistic about future growth through strategic partnerships and AI-driven efficiencies.
Company Guidance
During the first quarter of 2025, DarioHealth provided key guidance on several metrics that highlight their strategic and financial performance. The company signed 14 new clients, leading to a total client base of 97, up from 83 at the end of 2024, with a renewal rate above 90%. They achieved 17.5% non-GAAP gross margins and maintained over 81% gross margins in their core B2B2C business. Operating expenses declined by 35% year-over-year. DarioHealth reported a $6.75 million revenue for the quarter, a 17% increase year-over-year, although sequential revenue was lower compared to Q4, partly due to shifts in large national health plan client scopes. The integration with Twill has bolstered their platform, which now supports five chronic conditions. Looking forward, they aim for operational cash flow break-even by the end of 2025, with further reductions in operating expenses anticipated to support scalable and profitable growth.
Strong Client Growth and Multi-Condition Contracts
DarioHealth signed 14 new clients in Q1 2025, including a national health plan, a regional plan, and 12 employer partners. More than 80% of those contracts are multi-condition, showing strong client acquisition and commitment to multi-condition care.
Significant Improvement in Operating Expenses and Gross Margins
Operating expenses declined by 35% year-over-year, and the company maintained over 81% gross margins in its core B2B2C business. Non-GAAP gross margins expanded to 70.5%, up from 62.4% in the first quarter of 2024.
Integration of Twill and AI-Driven Strategy
The acquisition and integration of Twill strengthened DarioHealth's leadership in the digital health industry. The AI-cubed strategy (AI to the third power) leverages artificial intelligence for operational efficiency, member engagement, and customer value, contributing to a projected 15% to 20% reduction in operating expenses over the next 12 to 18 months.
Revenue Growth and Expansion
DarioHealth delivered $6.75 million in revenue this quarter, a 17% increase year-over-year, driven by recurring revenue growth from B2B2C channels.

DarioHealth (DRIO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DRIO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2025
2025 (Q2)
-0.20 / -
-0.08
May 14, 2025
2025 (Q1)
-0.10 / -0.14
-0.230.00% (+0.06)
Mar 10, 2025
2024 (Q4)
-0.33 / -0.08
-0.4180.49% (+0.33)
Nov 07, 2024
2024 (Q3)
-0.22 / -0.25
-0.4948.98% (+0.24)
Aug 08, 2024
2024 (Q2)
-0.45 / -0.08
-0.5886.21% (+0.50)
May 15, 2024
2024 (Q1)
-0.29 / -0.20
-0.4555.56% (+0.25)
Mar 28, 2024
2023 (Q4)
-0.39 / -0.41
-0.422.38% (+0.01)
Nov 02, 2023
2023 (Q3)
-0.52 / -0.49
-0.6423.44% (+0.15)
Aug 10, 2023
2023 (Q2)
-0.51 / -0.58
-0.7421.62% (+0.16)
May 11, 2023
2023 (Q1)
-0.50 / -0.45
-0.7439.19% (+0.29)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DRIO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2025
$0.72$0.66-8.33%
Mar 10, 2025
$0.73$0.67-8.22%
Nov 07, 2024
$0.96$0.97+1.04%
Aug 08, 2024
$0.93$0.83-10.75%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does DarioHealth Corp (DRIO) report earnings?
DarioHealth Corp (DRIO) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
    What is DarioHealth Corp (DRIO) earnings time?
    DarioHealth Corp (DRIO) earnings time is at Aug 18, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DRIO EPS forecast?
          DRIO EPS forecast for the fiscal quarter 2025 (Q2) is -0.2.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis